DOCSLIB.ORG

UNITED STATES PATENT OFFICE 2,321,594 AMNO CARBOXYLIC ACD ESTERS of HIGHER MOLECULAR WEGHT CARBOX YLIC Monoesters of Glycols Benjamin R

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
UNITED STATES PATENT OFFICE 2,321,594 AMNO CARBOXYLIC ACD ESTERS of HIGHER MOLECULAR WEGHT CARBOX YLIC Monoesters of Glycols Benjamin R Patented June 15, 1943 2,321,594 UNITED STATES PATENT OFFICE 2,321,594 AMNO CARBOXYLIC ACD ESTERS OF HIGHER MOLECULAR WEGHT CARBOX YLIC MonoESTERs oF GLYcoLs Benjamin R. Harris, Chicago, Ill. No Drawing. Application February 5, 1941, Serial No. 3,489 14 Claims. (C. 260-404) This invention relates to the preparation of O new chemical compounds which are especially (8) ch,-0--Cich, useful for antiseptic, medicinal, preservative, bac CE tericidal, bacteriostatic, germicidal and fungicidal / plpOSes. s H-0--cent, A. At least many of the novel substances of the O C present invention, which, in use, are employed O particularly in the form of salts such as hydro chlorides, as hereinafter set forth, fall within the (4) gh-0--c Eas Scope of the general formula: O C H-0-- -CH O NB o--R O (5) CH-O--Citi, 5 bH, Yo-c-R &H-0-0-ch-c E-C Wherein NH, O O R-3- 20 (6) CB-O- - Cis is an acyl radical, O (E), R-C- Hi-o-c-CH-CH-cooH is the acyl radical of an amino-carboxylic acid NH, containing at least one primary amino group, 25 O and X is the residue of a glycol. CH-0--0 ults The novel substances of the present invention, (7) generally used in the form of their salts as indi Ho-b H-O-C-CH-CH-CH-CH cated hereinabove, may be regarded as amino NH, carboxylic acid esters of carboxylic acid mono 30 O esters of glycols, particularly higher molecular weight fatty acid mono-esters of glycols, espe (8) CI- 0-8-cube cially satisfactory being those derived from fatty acids containing from eight to fourteen carbon ch, atoms. 35 s C In order that the nature of the invention may & H-O- C-C-N./ become, more apparent, there are listed herein N below various of the novel substances which gen C erally are used in the form of salts, especially, O hydrochlorides, and fall within the scope of the 40 invention: (9) CE- 0-8-Citi, O H-0--CH-CH-CH-CH (1) CH-0--0. He NH, NH, &H-0- C-CE-NE 45 O CBI-CE (10) 9.H-0-- H-coh-oh, O (2) CH-O-C-C1s 50 &H-0--it-ch-oh-oh,NE b O bH, () cE-0--0 Has &E-o-o-ch-NE, bi-o-o-c-ch-in-KD OBE 2 2,821,594 The substances are prepared, preferably, by glycol, diethylene glycol, trimethylene glycol, tri converting the amino-carboxylic acid into its acyl ethylene glycol, butylene glycol, tetraethylene chloride or a salt of its acyl chloride, such as the glycol, pentaethylene glycol; hexaethylene glycol hydrochloride, and reacting the same with the and still higher homologues; higher molecular stoichiometric equivalent of the higher molecular weight glycols such as cetene glycol and other weight carboxylic acid mono-ester of the glycol. vicinal glycols; 1,10 dihydroxyoctadecene; 1,10 The following examples are illustrative of a dihydroxyoctadecane, and the like. method which has been found suitable for pre The carboxylic acid acyl radicals represented paring the various compounds which are dis by closed herein. It will be appreciated that other O . O methods may be utilized, that the proportions of R-3- reacting ingredients, times of reaction, order of in the general formula may be derived from steps, and temperatures may be varied and that various sources. Among such sources may be supplementary processes of purification and the mentioned the straight chain and branched like may be resorted to wherever found desirable chain, Saturated and unsaturated, carboxylic, or convenient. These and other variations and | aliphatic (including cycloaliphatic), fatty, aro modifications will be evident to those skilled in matic, hydroaromatic, and araliphatic acids in the art in the light of the guiding principles cluding acetic acid, propionic acid, butyric acid, which are disclosed herein: caproic acid, pimelic acid, caprylic acid, capric Ecomple A 20 acid, sebacic acid, behenic acid, arachidic acid, 22 grams of the acyl chloride of phenyl alanine cerotic acid, erucic acid, melissic acid, stearic hydrochloride and 29 grams of the lauric acid acid, oleic acid, ricinoleic acid, ricinelaidic acid, mono-ester of diethylene glycol were covered ricinostearolic acid, linoleic acid, linolenic acid, with chloroform and the resulting mixture Was lauric acid, myristic acid, palmitic acid, mixtures heated in an oil bath at 75 degrees C. to 92 de of any two or more of the above mentioned acids grees C. for about one-half hour. Hydrochloric or other acids, mixed higher fatty acids derived acid gas was evolved continuously during the from animal or vegetable sources, for example, heating period. The reaction mixture was then lard, coconut oil, rapeseed oil, sesame oil, palm heated at 100 degrees C., under reduced pres kernel oil, palm oil, olive oil, corn oil, cotton sure, to remove the remaining hydrochloric acid. 30 Seed oil, Sardine oil, tallow, soya bean oil, peanut On cooling, the product Solidified. It was then oil, castor oil, seal oils, whale oil, shark oil and ground and washed with hexane and the Col other fish oils, partially or completely hydrogen lected precipitate was melted in an Oven at 100 ated animal and vegetable oils such as those men degrees C. to drive of the hexane. The yield tioned; oxidized hydroxy and alpha-hydroxy was 33 grams of a product having a melting 3. 5 higher carboxylic, aliphatic and fatty and/or point of 96 degrees C. to 97 degrees C., and polymerized triglyceride oils; acyloxy carboxylic which, after grinding, Was a hard, White Solid, acids such as C17H35-CO-O-CH2-COOH: soluble in Water and consisting essentially of the acids such as i-hydroxy stearic acid, dihydroxy hydrochloride of the ester of phenyl alanine with palmitic acid, di-hydroxy-stearic acid, dihy the lauric acid mono-ester of diethylene glycol, 40 droxybehenic acid, alpha-hydroxy capric acid, said compound having the formula. alpha-hydroxy stearic acid, alpha-hydroxy palmitic acid, alpha-hydroxy lauric acid, alpha O hydroxy myristic acid, alpha-hydroxy coconut oil mixed fatty acids, alpha-hydroxy margaric acid, {D-on-on-o-o-o-eirN.Cl 45 alpha-hydroxy arachidic acid, and the like; fatty Eaccomple B and similar acids derived from various waxes Such as beeswax, spermaceti, montan wax, coc 20 grams of the hydrochloride of alpha-amino cerin, and carnauba wax and higher molecular isobutyryl chloride are reacted with 30 grams of Weight carboxylic acids derived, by oxidation and the caprylic acid mono-ester of diethylene glycol other methods, from paraffin wax, petroleum and under the conditions described in Example A. Similar hydrocarbons; resinic and hydroaromatic The product comprises essentially the hydrochlo acids such as hexahydrobenzoic acid, naphthenic ride of the ester of alpha-amino isobutyric acid acid and abietic acid; araliphatic and aromatic with the caprylic acid mono-ester of diethylene acids Such as phthalic acid, benzoic acid, glycol, said compound having the formula: 5 5 Twitchell fatty acids, naphthoic acid, pyridine N.HCl carboxylic acid; hydroxy aromatic acids such as Salicyclic acid, hydroxy benzoic and naphthoic CH-C-O -CH-O-CH-0---c Hs acids, and the like. It will be understood that bH, mixtures of any two or more of said acids may It will be understood that the Substances may, 60 be employed if desired and it will also be ap-. for certain purposes, be employed in the form of preciated that said acids may contain substituent impure reaction mixtures containing substan groups such as sulphate, sulphonic, nitrile, tial proportions of the effective compounds. Cyanogen, carbonyl, amide, amine, halogen, Where the substances are used for bactericidal, ketone and other groups. The acids may be em germicidal and like purposes, however, purifica ployed as such or in the form of their anhydrides, tion procedures may be employed to produce pure esters including mono-, di-, tri-glycerides and or substantially pure products. Those versed in the like, and acyl halides, or, in general, in the the art are familiar with the types of purifica form of any of their acylating compounds. Of tion methods which may be employed with ad particular utility, where the final compounds are vantage herein, particularly in the light of the O used as antiseptics, bactericides, germicides and disclosures made hereinabove. the like, are the unsubstituted fatty acids con The glycols whose derivatives, as set forth taining from eight to fourteen carbon atoms and hereinabove, comprise the subject matter of the their acyl halides, lauric acid or its acyl halide present invention, may be selected from a large or coconut oil mixed fatty acids or their acyl group including, by way of illustration, ethylene s halides being especially satisfactory. 2,821,594 3. The amino-carboxylic acids which are or may Among the bacteria, the metabolism of which be utilized in the preparation of the substances is strongly inhibited by many of the compounds include, among those previously mentioned and of the present invention, are the following: others, alpha-amino acetic acid, alpha-amino Staphylococcus aureus, Staphylococcus' albus, propionic acid, alpha-amino butyric acid, beta Sarcina lutea, Micrococcals tetragenus, Bacili amino butyric acid, alpha-amino-n-Valeric acid, coli, Aerobacter aerogenes, Ps, pyocyaneus, alpha-amino isobutyric acid, alpha-amino iso Proteus vulgaris. Many of the substances are valeric acid, phenyl-alanine, tyrosine, trypto also effective against pneumococcus. In addi phane, cystine, arginine, amino poly-carboxylic tion, the phenol coefficients of many of the com acids such as amino succinic acid, amino glutaric 10 pounds are Substantially higher than that of acid, amino citric acid, amino malonic phenol.
Load more

Recommended publications
  • Chemical Synthesis of a Very Long-Chain Fatty Acid, Hexacosanoic Acid (C26:0), and the Ceramide Containing Hexacosanoic Acid
    J Nutr Sci Vitaminol, 61, 222–227, 2015 Chemical Synthesis of a Very Long-Chain Fatty Acid, Hexacosanoic Acid (C26:0), and the Ceramide Containing Hexacosanoic Acid Yoshinori YAMAMOTO, Toshimasa ITOH and Keiko YAMAMOTO* Laboratory of Drug Design and Medicinal Chemistry, Showa Pharmaceutical University, 3–3165 Higashi-Tamagawagakuen, Machida, Tokyo 194–8543, Japan (Received December 24, 2014) Summary Hexacosanoic acid (C26:0) (1), a very long-chain fatty acid, is related to vari- ous diseases such as adrenoleukodystrophy (ALD), adrenomyeloneuropathy (AMN) and atherosclerosis. As the level of 1 higher than the normal is related to diseases above, hexa- cosanoic acid (1) and the ceramide 2, which contains 1, are thought to play an important role in various tissues. Hexacosanoic acid (1) is known to be a waxy solid and to be hard to dissolve in water as well as organic solvents. Due to this physical property, it is not easy to handle hexacosanoic acid (1) in a laboratory. Therefore, efficient chemical synthesis of the compounds 1 and 2 has not been reported. Here, we report a versatile synthetic method for hexacosanoic acid (1) and the ceramide 2 containing the fatty acid 1. Synthesis of hexa- cosanoic acid (1) was achieved by applying the coupling of two alkyl units as a key step. Ceramide 2 was efficiently synthesized by applying the reported procedure together with hexacosanoic acid (1) synthesized here. This synthetic strategy has an advantage of getting various carbon chain length fatty acids and their ceramides by using a variety of carbon chain units. This method is also applicable for large-scale synthesis.
    [Show full text]
  • • Waxes Are Simple Lipids Containing Fatty Acid Joined to Long Chin Alcohol
    Waxes • Waxes are simple lipids containing fatty acid joined to long chin alcohol • They are esters of saturated long chain FA and long chain alcohol • In plants they are coatings that prevent water loss by leaves. • They are water insoluble soft solids with low melting point. • The can be obtained from – Insects – Minerals • Paraffin • Beeswax – Plants – Animal • Carnuba • Cocoa butter • Spermaceti 6/28/2020 1 Beeswax • Beeswax is the purified wax obtained from honeycomb of hive bee, Apis mellifera Linn and other species. • White beeswax is obtained by treating yellow beeswax chemically with potassium permanganate, chromic acid or chlorine or charcoal • When cold, yellow wax is brittle and when broken, shows presence of a dull, granular, non-crystalline fracture. • Yellow wax is insoluble in water and sparingly soluble in cold alcohol. • It is completely soluble in chloroform, ether, and fixed or volatile oils, partly soluble in cold benzene or in carbon disulphide. 6/28/2020 2 Beeswax… • Beeswax contains – myricin, which is melissyl palmitate; melting point 64°C, – Free cerotic acid (C26H52O2), – Myricyl alcohol (C30H61OH) – Melissic acid, some unsaturated acids of the oleic series, ceryl alcohol, and 12 to 13% higher hydrocarbons are present. • Beeswax is used in the preparation of ointments, plaster, and polishes. 6/28/2020 3 Cocoa butter • Synonyms: theobroma oil, cocao beans, semina theobromatis. • obtained from roasted seeds of Theobroma cacao Linn. • Cocoa seeds contain nearly 50% of cocoa butter. preparation Separation of seed from pod Fermentation at 30-40°C for 3-6 days Roasting at 100-140°C Cooling & nibbling Hot rolling to get butter Purification 6/28/2020 4 Cocoa butter… • Cocoa butter is yellowish white solid and brittle below 25°C.
    [Show full text]
  • Peroxisomal Fatty Acid Beta-Oxidation in Relation to the Accumulation Of
    Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders. R J Wanders, … , A W Schram, J M Tager J Clin Invest. 1987;80(6):1778-1783. https://doi.org/10.1172/JCI113271. Research Article The peroxisomal oxidation of the long chain fatty acid palmitate (C16:0) and the very long chain fatty acids lignocerate (C24:0) and cerotate (C26:0) was studied in freshly prepared homogenates of cultured skin fibroblasts from control individuals and patients with peroxisomal disorders. The peroxisomal oxidation of the fatty acids is almost completely dependent on the addition of ATP, coenzyme A (CoA), Mg2+ and NAD+. However, the dependency of the oxidation of palmitate on the concentration of the cofactors differs markedly from that of the oxidation of lignocerate and cerotate. The peroxisomal oxidation of all three fatty acid substrates is markedly deficient in fibroblasts from patients with the Zellweger syndrome, the neonatal form of adrenoleukodystrophy and the infantile form of Refsum disease, in accordance with the deficiency of peroxisomes in these patients. In fibroblasts from patients with X-linked adrenoleukodystrophy the peroxisomal oxidation of lignocerate and cerotate is impaired, but not that of palmitate. Competition experiments indicate that in fibroblasts, as in rat liver, distinct enzyme systems are responsible for the oxidation of palmitate on the one hand and lignocerate and cerotate on the other hand. Fractionation studies indicate that in rat liver activation of cerotate and lignocerate to cerotoyl-CoA and lignoceroyl-CoA, respectively, occurs in two subcellular fractions, the endoplasmic reticulum and the peroxisomes but not in the mitochondria.
    [Show full text]
  • WO 2017/074902 Al 4 May 20 17 (04.05.2017) W P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/074902 Al 4 May 20 17 (04.05.2017) W P O P C T (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A61K 8/37 (2006.01) A61Q 19/00 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, A61K 31/215 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (21) International Application Number: KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, PCT/US2016/058591 MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (22) International Filing Date: OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, 25 October 2016 (25.10.201 6) SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (25) Filing Language: English ZW. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 62/247,803 29 October 20 15 (29. 10.20 15) US GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (71) Applicant: GLAXOSMITHKLINE CONSUMER TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, HEALTHCARE HOLDINGS (US) LLC [US/US]; 271 1 DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, Centerville Road, Suite 400, Wilmington, DE 19808 (US).
    [Show full text]
  • UC San Diego UC San Diego Previously Published Works
    UC San Diego UC San Diego Previously Published Works Title AMP-activated protein kinase activation ameliorates eicosanoid dysregulation in high-fat- induced kidney disease in mice. Permalink https://escholarship.org/uc/item/3b6163nf Journal Journal of lipid research, 60(5) ISSN 0022-2275 Authors Declèves, Anne-Emilie Mathew, Anna V Armando, Aaron M et al. Publication Date 2019-05-01 DOI 10.1194/jlr.m088690 Peer reviewed eScholarship.org Powered by the California Digital Library University of California AMPK ameliorates eicosanoids in HFD induced-CKD Declèves et al. AMP-activated protein kinase activation ameliorates eicosanoid dysregulation in high-fat–induced kidney disease in mice Anne-Emilie Declèves1,2*, Anna V. Mathew3*, Aaron M. Armando4, Xianlin Han5, Edward Downloaded from A. Dennis4,6, Oswald Quehenberger4,7 and Kumar Sharma1,8. 1Institute of Metabolomic Medicine, University of California San Diego; 2Laboratory of www.jlr.org Metabolic and Molecular Biochemistry, Faculty of Medicine, Université of Mons; 3Division at Univ of California - San Diego Serials/Biomed Lib 0699, on March 18, 2019 of Nephrology, Department of Internal Medicine, University of Michigan; 4Department of Pharmacology, University of California, San Diego; 5Barshop Institute of Aging, Department of Medicine, University of Texas Health San Antonio, 6Department of Chemistry and Biochemistry, University of California, San Diego; 7Department of Medicine, University of California, San Diego; 8Center for Renal Precision Medicine, Division of Nephrology, Department
    [Show full text]
  • Fatty Acid Composition of Oil from Adapted Elite Corn Breeding Materials Francie G
    Food Science and Human Nutrition Publications Food Science and Human Nutrition 9-1995 Fatty Acid Composition of Oil from Adapted Elite Corn Breeding Materials Francie G. Dunlap Iowa State University Pamela J. White Iowa State University, [email protected] Linda M. Pollak United States Department of Agriculture Thomas J. Brumm MBS Incorporated, [email protected] Follow this and additional works at: http://lib.dr.iastate.edu/fshn_hs_pubs Part of the Agronomy and Crop Sciences Commons, Bioresource and Agricultural Engineering Commons, Food Science Commons, and the Nutrition Commons The ompc lete bibliographic information for this item can be found at http://lib.dr.iastate.edu/ fshn_hs_pubs/2. For information on how to cite this item, please visit http://lib.dr.iastate.edu/ howtocite.html. This Article is brought to you for free and open access by the Food Science and Human Nutrition at Iowa State University Digital Repository. It has been accepted for inclusion in Food Science and Human Nutrition Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Fatty Acid Composition of Oil from Adapted Elite Corn Breeding Materials Abstract The fatty acid composition of corn oil can be altered to meet consumer demands for “healthful” fats (i.e., lower saturates and higher monounsaturates). To this end, a survey of 418 corn hybrids and 98 corn inbreds grown in Iowa was done to determine the fatty acid composition of readily-available, adapted, elite corn breeding materials. These materials are those used in commercial hybrid production. Eighty-seven hybrids grown in France (18 of which also were grown in lowa) were analyzed to determine environmental influence on fatty acid content.
    [Show full text]
  • View Data Sheet
    PRODUCT DATA SHEET Hexacosanoic acid Catalog number: 1251 Molecular Weight: 397 Common Name: C26:0 Fatty acid; cerotic acid Storage: room temperature Source: synthetic Purity: TLC: 99%, GC >99% Solubility: chloroform, ethyl ether TLC System: hexane/ethyl ether/acetic acid CAS number: 506-46-7 (85:15:1 by vol.) Molecular Formula: C 26 H52 O2 Appearance: solid HO O Application Notes: This high purity very long chain fatty acid (VLCFA) is ideal as a standard and for biological studies. X-linked adrenoleukodystrophy (X-ALD) is an inherited disorder of peroxisomal metabolism and is characterized by deficient β- oxidation of saturated very long chain fatty acids such as hexacosanoic acid. Indeed, some studies show hexacosanoic acid as the most prevalent VLCFA in X-ALD, causing oxidative damage of proteins early on in the disease. 1 Hexacosanoic acid has also been found to be closely linked to a high risk of atherosclerosis and metabolic syndrome. 2 In plants, VLCFA are converted to long chain hydrocarbons which are used to make waxes that are essential to their survival. 3 VLCFA acylated to sphingolipids are critical in many biological functions 4 and substantial amounts are found to be amide-linked to the long- chain sphingoid base sphinganine, forming a ceramide, which constitutes the lipid backbone of sphingomyelin and other sphingolipids. VLCFA can often be found in esterified linkages with cholesterol, gangliosides, galactocerebrosides, sphingomyelin, and phosphatidylcholine. In myelin, VLCFA are important in increasing the structural stability. Selected References: 1. S. Fourcade et al. “Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy” Human Molecular Genetics , vol.
    [Show full text]
  • Relationship Between Dietary Intake of Fatty Acids and Disease Activity in Pediatric Inflammatory Bowel Disease Patients
    Relationship between Dietary Intake of Fatty Acids and Disease Activity in Pediatric Inflammatory Bowel Disease Patients A thesis submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirements for the degree of Master of Science in the Department of Nutrition of the College of Allied Health Sciences by Michael R. Ciresi B.S. The Ohio State University June 2008 Committee Chair: Grace Falciglia, Ph.D. Abstract Background. Crohn’s disease (CD) and ulcerative colitis (UC), collectively known as inflammatory bowel disease (IBD), are chronic illnesses that affect predominately the gastrointestinal tract. The pathogenesis and etiology remain unclear but the importance of environmental factors, in particular diet, is evidenced by the increased incidence rates of the recent decades that genetic inheritance cannot account for. In particular, the quantity of fatty acid consumption has been consistently linked with IBD risk. While several studies have investigated the connections between diet, etiology, signs and symptoms associated with IBD, very few have explored the relationship between disease state and specific fatty acid intake in the pediatric IBD population. Methods. In this cross-sectional study, 100 pediatric patients from Cincinnati Children’s Hospital and the Hospital for Sick Children in Toronto with diagnosed IBD (73 with Crohn’s disease (CD) and 27 with ulcerative colitis (UC)) were included. Three-day diet records were collected from the patients for the assessment of their dietary intake. The abbreviated Pediatric Crohn’s Disease Activity Index (PCDAI), the abbreviated Ulcerative Colitis Activity Index (PUCAI), and markers of inflammation (lipopolysaccharide binding protein (LBP) and S100A12) were used to assess disease severity.
    [Show full text]
  • Fatty Acid Mass Spectrometry Protocol Updated 12/2010 by Aaron Armando
    Fatty Acid Mass Spectrometry Protocol Updated 12/2010 By Aaron Armando Synopsis: This protocol describes the standard method for extracting and quantifying free fatty acids and total fatty acids via negative ion chemical ionization GC-MS. Samples can be cells, media, plasma, or tissue. Methanol, HCl and deuterated internal standards are added to cell or media samples that are then extracted with iso-octane and derivatized to pentafluorobenzyl esters for GC analysis. Samples are then analyzed by GC-MS along with a standard curve consisting of unlabeled primary fatty acid standards mixed with the same deuterated internal standards added to the samples. The ratios of unlabeled to labeled standard are measured for the standard curve and used to determine unlabeled analyte levels for samples. All operating parameters for the instrument are contained in the raw data files, all other conditions are listed here. Storage: All samples and standards are stored under argon at -20°C. Internal Standards The internal standard contains 25 ng (0.25 ng/µl) of each of the following deuterated fatty acids in 100% ethanol: Name Abbrev. Company Amt. (mg) Cat. # Lauric Acid (d3) 12:0 CDN Isotopes 100 D-4027 Myristic Acid (d3) 14:0 Cambridge Isotopes 100 DLM-1039-0.1 Pentadecanoic Acid (d3) 15:0 CDN Isotopes 100 D-5258 Palmitic Acid (d3) 16:0 CDN Isotopes 100 D-1655 Heptadecanoic Acid (d3) 17:0 CDN Isotopes 100 D-5255 Stearic Acid (d3) 18:0 CDN Isotopes 100 D-1825 Oleic Acid (d2) 18:1 Cambridge Isotopes 100 DLM-689-0.1 Arachidic Acid (d3) 20:0 CDN Isotopes 0.1/200uL D-5254 Arachidonic Acid (d8) 20:4 Cayman Chemical 1/100uL 390010 Eicosapentaenoic Acid (d5) 20:5 Cayman Chemical 100 10005056 Behenic Acid (d3) 22:0 CDN Isotopes 0.1/200uL D-5708 Docosahexaenoic Acid (d5) 22:6 Cayman Chemical 100 10005057 Lignoceric Acid (d4) 24:0 CDN Isotopes 100 D-6167 Cerotic Acid (d4) 26:0 CDN Isotopes 100 D-6145 Stocks are maintained at 10X concentration (2.5 ng/ul) in 100% ethanol and diluted to working strength at extraction time.
    [Show full text]
  • ( Vaccinium Myrtillus L . ) And
    Food Chemistry 354 (2021) 129517 Contents lists available at ScienceDirect Food Chemistry journal homepage: www.elsevier.com/locate/foodchem Analysis of composition, morphology, and biosynthesis of cuticular wax in wild type bilberry (Vaccinium myrtillus L.) and its glossy mutant Priyanka Trivedi a,1, Nga Nguyen a,1, Linards Klavins b, Jorens Kviesis b, Esa Heinonen c, Janne Remes c, Soile Jokipii-Lukkari a, Maris Klavins b, Katja Karppinen d, Laura Jaakola d,e, Hely Haggman¨ a,* a Department of Ecology and Genetics, University of Oulu, FI-90014 Oulu, Finland b Department of Environmental Science, University of Latvia, LV-1004 Riga, Latvia c Centre for Material Analysis, University of Oulu, FI-90014 Oulu, Finland d Department of Arctic and Marine Biology, UiT The Arctic University of Norway, NO-9037 Tromsø, Norway e NIBIO, Norwegian Institute of Bioeconomy Research, NO-1431 Ås, Norway ARTICLE INFO ABSTRACT Keywords: In this study, cuticular wax load, its chemical composition, and biosynthesis, was studied during development of Cuticular wax wild type (WT) bilberry fruit and its natural glossy type (GT) mutant. GT fruit cuticular wax load was comparable Fruit cuticle with WT fruits. In both, the proportion of triterpenoids decreased during fruit development concomitant with Gene expression increasing proportions of total aliphatic compounds. In GT fruit, a higher proportion of triterpenoids in cuticular Glossy type mutant wax was accompanied by a lower proportion of fatty acids and ketones compared to WT fruit as well as lower Triterpenoids Wax composition density of crystalloid structures on berry surfaces. Our results suggest that the glossy phenotype could be caused Chemical compounds studied in this article: by the absence of rod-like structures in GT fruit associated with reduction in proportions of ketones and fatty β-Amyrin (PubChem CID: 73145) acids in the cuticular wax.
    [Show full text]
  • 2,406,336 United States Patent Office
    Patented Aug. 27,’ 1946 2,406,336 UNITED STATES PATENT OFFICE ‘ - V ‘ 12,406,336" ' ' WAXES taszIeA-uer, South Orange, J. No‘ Drawings ‘ ‘Application’ August 21, 1942, Serial No. 455,613 r0" claims. (CL 106-40) - I 2 FIELD or INVENTI‘ON J anon This invention relates to the modi?cation 0f the properties of Waxes. The invention is par a. Main constituents: ticularly concerned with treatment of organic 1’. Palm-itin ester-type waxes or waxlike materials, as dis 2. Palmitic acid tinguished from certain hydrocarbons which are b. Subordinate constituents: L Dibas-ic' acids sometimes termed waxes. For instance; while 2-. Soluble acids paraf?n, montan wax and cere‘sin,ua're= sometimes referred'to as waxes, they are not “true” waxes‘. Bayberry was: In contrast, the invention is concerned with- the 10 treatment of ester-type waxes such, for instance, as listed just below: , Beeswax Although some of the'f'oreg‘oing lis‘t'are o'f ani Inal and some of vegetable origin, I believe them, Carnauba wax 15 Spermaceti wax all to“ be‘ organic~ is'oc‘olloids, i. e., colloidal sub Candelilla wax stances‘ in‘ which; the dispersed phase and the Japan Wax ' dispersion‘ medium‘ are: both of the same chemical Bayberry (Myrtle)v Wax composition; though present in different physical states: ' v i These waxes are esters of long chain aliphatic 20 There‘ are» other wax ,or wax-like materials alcohols with long chain aliphatic fatty acids,‘ as which are‘ organic; isoco'l-loi'ds andwhich may be is indicated in the following listing of some of treated in accordance with the“ invention'jfor the major constituents of various oi the: waxes instance, synthetic wax-11x6- products containing above mentioned.
    [Show full text]
  • Biochemistry Prologue to Lipids
    Paper : 05 Metabolism of Lipids Module: 01 Prologue to Lipids Principal Investigator Dr. Sunil Kumar Khare, Professor, Department of Chemistry, IIT-Delhi Paper Coordinator and Dr. Suaib Luqman, Scientist (CSIR-CIMAP) Content Writer & Assistant Professor (AcSIR) CSIRDr. Vijaya-CIMAP, Khader Lucknow Dr. MC Varadaraj Content Reviewer Prof. Prashant Mishra, Professor, Department of Biochemical Engineering and Biotechnology, IIT-Delhi 1 METABOLISM OF LIPIDS Biochemistry Prologue to Lipids DESCRIPTION OF MODULE Subject Name Biochemistry Paper Name 05 Metabolism of Lipids Module Name/Title 01 Prologue to Lipids 2 METABOLISM OF LIPIDS Biochemistry Prologue to Lipids 1. Objectives To understand what is lipid Why they are important How they occur in nature 2. Concept Map LIPIDS Fatty Acids Glycerol 3. Description 3.1 Prologue to Lipids In 1943, the term lipid was first used by BLOOR, a German biochemist. Lipids are heterogeneous group of compounds present in plants and animal tissues related either actually or potentially to the fatty acids. They are amphipathic molecules, hydrophobic in nature originated utterly or in part by thioesters (carbanion-based condensations of fatty acids and/or polyketides etc) or by isoprene units (carbocation-based condensations of prenols, sterols, etc). Lipids have the universal property of being: i. Quite insoluble in water (polar solvent) ii. Soluble in benzene, chloroform, ether (non-polar solvent) 3 METABOLISM OF LIPIDS Biochemistry Prologue to Lipids Thus, lipids include oils, fats, waxes, steroids, vitamins (A, D, E and K) and related compounds, such as phospholipids, triglycerides, diglycerides, monoglycerides and others, which are allied more by their physical properties than by their chemical assests.
    [Show full text]